Free Trial

Avanza Fonder AB Sells 2,779 Shares of Veeva Systems Inc. (NYSE:VEEV)

Veeva Systems logo with Medical background

Avanza Fonder AB decreased its holdings in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 25.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,156 shares of the technology company's stock after selling 2,779 shares during the period. Avanza Fonder AB's holdings in Veeva Systems were worth $1,848,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in VEEV. Venturi Wealth Management LLC increased its stake in Veeva Systems by 2,716.7% in the 4th quarter. Venturi Wealth Management LLC now owns 169 shares of the technology company's stock worth $36,000 after buying an additional 163 shares during the period. Linonia Partnership LP grew its stake in Veeva Systems by 42.1% in the 4th quarter. Linonia Partnership LP now owns 1,202,972 shares of the technology company's stock worth $252,925,000 after acquiring an additional 356,300 shares in the last quarter. VSM Wealth Advisory LLC purchased a new position in shares of Veeva Systems during the fourth quarter worth approximately $42,000. Amundi raised its stake in shares of Veeva Systems by 9.8% during the fourth quarter. Amundi now owns 459,044 shares of the technology company's stock valued at $99,750,000 after acquiring an additional 40,884 shares in the last quarter. Finally, Townsquare Capital LLC boosted its holdings in shares of Veeva Systems by 3.1% in the fourth quarter. Townsquare Capital LLC now owns 4,912 shares of the technology company's stock valued at $1,033,000 after purchasing an additional 150 shares during the period. Institutional investors own 88.20% of the company's stock.

Insider Buying and Selling

In other news, insider Thomas D. Schwenger sold 1,200 shares of the firm's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $220.97, for a total transaction of $265,164.00. Following the completion of the transaction, the insider now directly owns 25,889 shares in the company, valued at $5,720,692.33. This trade represents a 4.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy S. Cabral sold 315 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $289.72, for a total transaction of $91,261.80. Following the sale, the director now directly owns 5,500 shares in the company, valued at $1,593,460. This trade represents a 5.42% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,184 shares of company stock valued at $1,376,179. 10.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

VEEV has been the subject of several analyst reports. Needham & Company LLC increased their price objective on Veeva Systems from $270.00 to $300.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Raymond James raised their price target on Veeva Systems from $285.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 29th. KeyCorp dropped their target price on shares of Veeva Systems from $260.00 to $250.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Robert W. Baird raised their price target on shares of Veeva Systems from $283.00 to $285.00 and gave the stock an "outperform" rating in a report on Thursday, March 6th. Finally, Wall Street Zen upgraded Veeva Systems from a "hold" rating to a "buy" rating in a research note on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $269.80.

Get Our Latest Report on VEEV

Veeva Systems Price Performance

Shares of VEEV traded down $6.70 on Thursday, hitting $281.85. The company's stock had a trading volume of 2,017,512 shares, compared to its average volume of 1,144,034. The company has a market capitalization of $45.86 billion, a PE ratio of 69.59, a PEG ratio of 1.89 and a beta of 0.99. Veeva Systems Inc. has a fifty-two week low of $176.41 and a fifty-two week high of $291.68. The company has a 50 day moving average price of $239.45 and a 200 day moving average price of $231.56.

Veeva Systems (NYSE:VEEV - Get Free Report) last released its earnings results on Wednesday, May 28th. The technology company reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.23. Veeva Systems had a return on equity of 13.56% and a net margin of 25.07%. The firm had revenue of $759.04 million for the quarter, compared to analyst estimates of $728.38 million. During the same quarter in the prior year, the firm posted $1.50 earnings per share. The company's quarterly revenue was up 16.7% on a year-over-year basis. On average, equities analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems Profile

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Featured Articles

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines